GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

The iShares Core Dividend Growth's holdings lack clear focus since the fund is not prioritizing growth or more defensive ...

Shares Expanded Tech Sector has seen a significant rebound but remains fairly valued with a mixed technical outlook. Learn ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...